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IL-1b produced by phagocytes is important for
protection against the mucosal pathogen Staphylo-
coccus aureus. Processing and maturation of this
cytokine requires activation of the multiprotein
inflammasome complex. We observed that the
bacterial cell wall component peptidoglycan (PGN)
must be particulate and internalized via phagocytosis
to activate NLRP3 inflammasomes and IL-1b
secretion. In the context of S. aureus infection of
macrophages, we find that phagocytosis and lyso-
zyme-based bacterial cell wall degradation are
necessary to induce IL-1b secretion. Further, an
S. aureus enzyme, PGN O-acetyltransferase A, previ-
ously demonstrated to make cell wall PGN resistant
to lysozyme, strongly suppresses inflammasome
activation and inflammation in vitro and in vivo. These
observations demonstrate that phagocytosis and
lysozyme-based cell wall degradation of S. aureus
are functionally coupled to inflammasome activation
and IL-1b secretion and illustrate a case whereby
a bacterium specifically subverts IL-1b secretion
through chemical modification of its cell wall PGN.
INTRODUCTION
Although Staphylococcus aureus permanently colonizes
mucosal tissues in at least 20% of individuals, it can also cause
pathological conditions ranging from minor skin and soft tissue
infections to life-threatening invasive diseases (Foster, 2005).
To survive in the host, S. aureus must evade immune defenses.
Recent reports suggest several mechanisms by which staphylo-
cocci protect themselves, including resistance to specific anti-
microbial peptides, neutralization of reactive oxygen species
(ROS), inactivation of complement, inhibition of neutrophil migra-38 Cell Host & Microbe 7, 38–49, January 21, 2010 ª2010 Elsevier Intion, and evasion of phagocytosis (reviewed in Foster, 2005;
Rooijakkers et al., 2005).
IL-1b is a key cytokine in orchestrating host defense against
S. aureus (Hultgren et al., 2002; Kielian et al., 2004; Miller et al.,
2006, 2007; Verdrengh et al., 2004), yet little is known about
how the organism counters IL-1b-mediated immunity. Miller
et al. reported that mice genetically deficient in production of
IL-1b or unable to respond to the cytokine are exquisitely sensi-
tive to cutaneous infection with the bacteria (Miller et al., 2006,
2007). Others have similarly shown that IL-1 signaling is impor-
tant for defense against systemic and brain infections and in
a septic arthritis model (Hultgren et al., 2002; Kielian et al.,
2004; Verdrengh et al., 2004). The primary role for IL-1b in host
defense against S. aureus appears to be in regulating neutrophil
recruitment to sites of infection. Although some reports suggest
that S. aureus can respond to the presence of IL-1bwith upregu-
lation of virulence traits (Kanangat et al., 2007; McLaughlin and
Hoogewerf, 2006), no studies to date have explored the capacity
of S. aureus to limit production of IL-1b by the host immune
system.
Secretion of IL-1b is tightly controlled. While release of many
inflammatory cytokines and chemokines requires a single signal,
such as that from a Toll-like receptor, secretion of IL-1b requires
at least two specific signals. First, a transcriptional response is
activated, leading to production of pro-IL-1b. A second signal
causes pro-IL-1b to be processed by caspase-1 and released
from cells. In the context of antibacterial host defense, the first
signal may be provided by Toll-like receptors such as TLR2 or
TLR4. Typically, activation of these receptors alone is not
sufficient to trigger release of mature IL-1b. The second signal
stimulates assembly of a multiprotein complex called the inflam-
masome, which regulates activation of caspase-1. One of the
best-characterized inflammasomes consists of NLRP3 (also
called Cryopyrin or Nalp3), ASC, and caspase-1, although other
complexes based on Nalp1 or Ipaf have been reported (Martinon
and Tschopp, 2004).
Cell walls of Gram-positive bacteria contain many compo-
nents that are recognized by the innate immune system. These
rigid structures are macromolecular assemblies of crosslinkedc.
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proteins. PGN, the core component of virtually all bacterial
cell walls, is a polymer of b(1–4)-linked N-acetylglucosamine
(GlcNAc) and N-acetylmuramic acid (MurNAc), crosslinked by
short peptides. The crosslinking peptides contain m-diaminopi-
melic acid in all Gram-negative bacteria and in Gram-positive
bacilli (DAP-type PGN). Most other Gram-positive bacteria,
including S. aureus, have L-lysine instead (Lys-type PGN) (Dziar-
ski, 2004). Muramyl dipeptide (MDP), one MurNAc linked to two
peptides of this polymer, is the minimal essential structure of
bacterial PGN required for adjuvant activity (Inohara et al.,
2003). MDP is present in practically all Gram-positive and
Gram-negative bacteria and is detected by Nod2, a cytosolic
receptor that activates NF-kB (Inohara et al., 2005). Polyanionic
teichoic acids are composed of wall teichoic acid (WTA) and
lipoteichoic acid (LTA). WTA is covalently linked to the PGN,
whereas LTA is a macroamphiphile with its glycolipid anchored
in the membrane and its poly(glycerophosphate) chain extending
into the wall (Neuhaus and Baddiley, 2003). LTA is sensed by
TLR2 (Morath et al., 2002; Schwandner et al., 1999). It is not
clear that any of these cell wall components are sufficient to acti-
vate inflammasomes and induce IL-1b secretion from mouse
macrophages.
Certain inert inflammatory stimuli such as aluminum salt
crystal (alum), silica, and asbestos can trigger inflammasome
activation in macrophages, and growing evidence suggests
that the particulate nature of these stimuli is important for this
activity (Dostert et al., 2008, 2009; Eisenbarth et al., 2008; Fran-
chi and Nu´n˜ez, 2008; Hornung et al., 2008; Li et al., 2008; Sharp
et al., 2009). It is not clear how these diverse, essentially indigest-
ible particles are sensed and trigger inflammasome activation.
Two recent reports have suggested that particle-induced
production of ROS may be involved (Cassel et al., 2008; Dostert
et al., 2008). Alternatively, Hornung et al. have suggested that
such particles cause lysosomal swelling and rupture and that
release of lysosomal enzymes into the cytoplasm triggers activa-
tion of the NLRP3 inflammasome (Hornung et al., 2008).
Less is currently known about how extracellular microbial
stimuli activate IL-1b release or whether the physical nature of
the exposure (soluble versus particulate delivery) influences
this inflammatory response. Mariathasan et al. have previously
demonstrated that exposure to S. aureus can activate the
NLRP3 inflammasome in LPS-pretreated mouse macrophages
and trigger release of some IL-1b (Mariathasan et al., 2006).
Similarly, in human cells, antibiotic-killed S. aureus and purified
cell wall PGN have been demonstrated to induce IL-1b secretion
(Wang et al., 2000). In this study, we demonstrate that S. aureus
PGN must be particulate to activate NLRP3 inflammasomes and
IL-1b secretion in mouse macrophages and that the particles
must be internalized via phagocytosis. Furthermore, although
this phagocytic process triggers production of ROS by the
NADPH phagocyte oxidase, ROS production is not required.
Instead, we show that lysozyme-dependent degradation of
PGN within phagolyosomes is necessary to induce IL-1b secre-
tion from macrophages. We show that live S. aureus strongly
suppresses this response by specifically making its PGN resis-
tant to lysozyme. While live S. aureus can stimulate some inflam-
masome activation, mutant bacteria unable to block lysozyme
induce much more inflammasome activation and inflammationCellin vitro and in vivo. The study shows that bacterial cell wall degra-
dation in macrophage phagosomes is functionally linked to
activation of the NLRP3 inflammasome and IL-1b secretion to
mount an efficient immune response against extracellular bacte-
rial infection.
RESULTS
In order to examine the mechanisms by which S. aureus induces
IL-1b secretion from macrophages, we stimulated mouse bone
marrow-derived macrophages (BMDMs) with S. aureus PGN
for 18 hr. Consistent with these previous reports, we observed
release of exclusively the mature processed 17 kDa form of
IL-1b into the supernatant, as determined by immunoblotting
(Figure 1A) and ELISA (Figure 1B). A combination of Pam3CSK4
lipopeptide and MDP activated cellular production of the
35 kDa pro-IL-1b, but did not trigger processing and release of
the mature p17 form. PGN-induced IL-1b was due to PGN and
not contaminants such as bacterial toxins, since boiling, trypsin
treatment, SDS treatment, and phenol extraction (Dziarski and
Gupta, 2005) did not ablate cytokine production (Figure S1A).
The structure of PGN depends on the organism from which it is
derived (Figure S2A). Martinon et al. have demonstrated that the
DAP-type PGN from E. coli is sensed by the NLRP3 inflamma-
some, resulting in activation of caspase-1 causing maturation
and secretion of IL-1b (Martinon et al., 2004). S. aureus produces
Lys-type PGN, and we therefore determined whether this type of
PGN is also sufficient to activate the NLRP3 inflammasome.
Macrophages from animals deficient in NLRP3, ASC, or cas-
pase-1 failed to produce IL-1b in response to S. aureus PGN
(Figure 1C), although IL-1b secretion was normal in Ipaf/
macrophages. TNF-a induction was unaffected (Figure 1D).
In addition to the core peptide crosslinked carbohydrate, PGN
preparations typically contain LTA, which, via Toll-like receptor 2
(TLR2), would be sufficient to provide the first signal for pro-IL-1b
production. Indeed, S. aureus PGN-induced IL-1b production is
inhibited in macrophages from TLR2-deficient mice (data not
shown). However, the source of the second signal is less clear.
MDP (Figure S2A) is the minimal essential structure of bacterial
PGN required for adjuvant activity and is detected by the cyto-
solic receptor Nod2 (Inohara et al., 2005). There are conflicting
reports as to whether Nod2 is able to activate caspase-1 and
IL-1b maturation and release in response to MDP (Hsu et al.,
2008; Kanneganti et al., 2007a; Maeda et al., 2005; Marina-
Garcı´a et al., 2008; Netea et al., 2005; Pan et al., 2007), and it
is unknown whether Nod2 is responsible for PGN-induced
IL-1b secretion. We therefore compared IL-1b secretion from
wild-type and Nod2/ macrophages in response to S. aureus
PGN. Nod2/ cells produced large amounts of IL-1b in
response to PGN, indicating that inflammasome activation was
intact. The overall levels of IL-1b (Figure 1E) and TNF-a (Figure 1F)
produced were reduced slightly in Nod2/ cells, indicating that
Nod2 participates in PGN sensing but is not required for inflam-
masome activation. Further Nod2/ cells produce mature IL-1b
equally as well as wild-type cells in response to PGN when the
cells are primed with LPS to stimulate pro-IL-1b (Figure S1B).
Consistent with these data, we observed that no combination
of pure TLR2 and Nod2 agonists is sufficient for inflammasome
activation and secretion of mature IL-1b (Figure 2A). AllHost & Microbe 7, 38–49, January 21, 2010 ª2010 Elsevier Inc. 39
Figure 1. S. aureus PGN Activates the NLRP3 Inflammasome in Mouse BMDMs
(A) PGN induces secretion of mature IL-1b from mouse bone marrow-derived macrophages (BMDMs). BMDMs were stimulated with Pam3CSK4 (1 mg/ml) and
MDP (20 mg/ml) together or with PGN (20 mg/ml) alone for 18 hr. Cell lysates (CL) and supernatants (SN) were analyzed for maturation and secretion of IL-1b by
immunoblot. Arrows indicate the appropriate sizes of pro-IL-1b (p35) and mature IL-1b (p17).
(B) BMDMs were stimulated with the indicated doses of PGN for 18 hr, and secretion of mature IL-1b and TNF-a into supernatants was measured by ELISA. Data
are presented as mean ±SD.
(C and D) S. aureus PGN-induced IL-1b secretion is dependent on the NLRP3 inflammasome. BMDMs of wild-type (WT) and various gene-deficient mice were
stimulated with PGN (10 mg/ml) for 18 hr, and secretion of IL-1b (C) and TNF-a (D) were measured by ELISA. Data are presented as mean ±SD.
(E and F) S. aureus PGN-induced IL-1b secretion is does not require Nod2. BMDMs of wild-type (WT) and Nod2-deficient mice were stimulated with the indicated
stimuli for 18 hr, and secretion of IL-1b (E) and TNF-a (F) were measured by ELISA. PGN (10 mg/ml), Pam3CSK4 (1 mg/ml), MDP (10 mg/ml). See also Figure S1.
Cell Host & Microbe
S. aureus Cell Wall Modification Blocks Host IL-1bcombinations tested, except MDP on its own, triggered secre-
tion of TNF-a (Figure 2B). When macrophages treated overnight
with TLR2/Nod2 agonists were pulsed for 2 hr with ATP, we
observed IL-1b secretion that paralleled TNF-a production (Fig-
ure 2C), directly demonstrating that these agonists are sufficient
to stimulate pro-IL-1b accumulation but not processing and
secretion of the mature cytokine.
Unlike soluble stimuli such as MDP, Pam3CSK4, and LTA, PGN
is an insoluble particle. Macrophages bind these particles and
internalize them via phagocytosis, after which the particles40 Cell Host & Microbe 7, 38–49, January 21, 2010 ª2010 Elsevier Inreside in an acidified phagolysosome for many hours (Figures
S3A and S3B). To determine whether the particulate form of
PGN is important for IL-1b releasing activity, we treated PGN
with mutanolysin or lysostaphin to solubilize the material (Four-
nier and Philpott, 2005). These enzymes cleave different parts
of PGN without degrading the MDP component (Figures S2A
and S2B). Macrophages stimulated for 18 hr with even very
high doses of the mutanolysin-digested PGN or lysostaphin-
digested PGN failed to secrete IL-1b (Figure 2D). In contrast,
solubilization of the particles had little or no effect on thec.
Figure 2. PGN Must Be Particulate to Induce IL-1b Secretion
(A and B) S. aureus PGN-induced IL-1b secretion cannot be reproduced using known stimulatory soluble components. BMDMs were stimulated with PGN or the
indicated soluble stimuli for 18 hr, and secretion of mature IL-1b and TNF-a was measured by ELISA.
(C) Cells stimulated as in (A) were additionally treated with 5 mM ATP for the final 2 hr to activate IL-1b processing and release. Release of mature IL-1b was
measured by ELISA.
(D and E) S. aureus PGN must be particulate to induce IL-1b. BMDMs were stimulated with PGN or various doses of mutanolysin-digested PGN (mutano-PGN) or
lysostaphin-digested PGN (lysosta-PGN) for 18 hr, and secretion of IL-1b was measured by ELISA.
(F) Cells stimulated as in (D) were additionally treated with 5 mM ATP for the final 2 hr to activate IL-1b processing and release. Release of mature IL-1b was
measured by ELISA. Results shown are representative of at least three independent experiments. Triplicate analysis was performed for ELISA. Data are pre-
sented as mean + SD. See also Figure S2.
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IL-1b in the cells was unaffected by solubilization since ATP
treatment of the stimulated cells triggered inflammasome activa-
tion and release of mature IL-1b for all stimuli (Figure 2F). Collec-
tively, these results indicate that the particulate nature of PGN is
essential for its IL-1b releasing activity.
Because PGN must be particulate to induce IL-1b release,
we hypothesized that phagocytosis is required. Fluorescently
labeled PGN is internalized by macrophages, as illustrated by
flow cytometry (Figure 3A), and this internalization is completely
blocked in the presence of cytochalasin D. Thus, the particlesCellare internalized via an actin-dependent phagocytic process.
We found that PGN-induced IL-1b and IL-18 secretion were
blocked in the presence of cytochalasin D (Figures 3B–3D).
Secretion of TNF-a was not affected by cytochalasin D (Fig-
ure 3E), and immunoblotting revealed that pro-IL-1b production
was not affected (Figure 3B). Cytochalasin D treatment did not
block ATP-induced release of IL-1b from cells exposed to PGN
(Figure 3F) or to mutanolysin-treated PGN (Figure 3G), indicating
both that the drug did not interfere with accumulation of pro-
IL-1b and that the mechanism of ATP-induced inflammasome
activation is actin independent. Taken together, these dataHost & Microbe 7, 38–49, January 21, 2010 ª2010 Elsevier Inc. 41
Figure 3. Phagocytosis of PGN Particles Is Required for Induction of IL-1b Secretion
(A) S. aureus PGN is internalized via actin-dependent phagocytosis. BMDMs were incubated with FITC-PGN (10 mg/ml) in the presence of DMSO (0.1%) (open
histogram) or the actin-disrupting agent cytochalasin D (5 mM) (gray histogram) for 4 hr. Phagocytosis was measured by flow cytometry.
(B–E) S. aureus PGN-induced IL-1b and IL-18 secretion are inhibited by cytochalasin D. BMDMs were preincubated with 0.1% DMSO or 5 mM cytochalasin D for
30 min and then stimulated with PGN (20 mg/ml) for 18 hr. IL-1b was measured by immunoblot (B) in cell lysates (CL) and supernatants (SN). BMDMs were pre-
incubated with 0.1% DMSO or 5 mM cytochalasin D for 30 min and then stimulated with PGN (20 mg/ml) for 3 hr. Cells were washed with culture media and incu-
bated for a further 15 hr, and secretion of IL-1b (C), IL-18 (D), and TNF-a (E) was measured by ELISA.
(F and G) Same procedure was performed as in (C)–(E) except that cells were pulsed with 5 mM ATP for the final 2 hr of the culture. PGN (20 mg/ml), mutano-PGN
(20 mg/ml). Thus, S. aureus PGN-induced pro-IL-1b accumulation is not dependent on actin-mediated phagocytosis. Results shown are representative of at least
three independent experiments. Triplicate analysis was performed for ELISA. Data are presented as mean + SD. See also Figure S3.
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particles to activate the inflammasome.
Recent reports have suggested that ROS produced during
phagocytosis may be an important unifying mechanism for in-
flammasome activation induced by diverse stimuli, including
ATP, asbestos, and silica particles (Cassel et al., 2008; Cruz
et al., 2007; Dostert et al., 2008). During phagocytosis, the
NADPH phagocyte oxidase assembles on phagosome mem-
branes and produces large amounts of ROS, although it is not
yet clear how many of these experimental inflammasome stimuli
actually activate the NADPH phagocyte oxidase. Importantly,
macrophages lacking the essential NADPH phagocyte oxidase
component gp91phox produce IL-1b normally in response to
silica particles, suggesting that this source of ROS may not be
critical (Dostert et al., 2009). PGN particles induce robust
NADPH phagocyte oxidase-dependent ROS production in
mouse BMDMs (Figure S3C). However, PGN-induced IL-1b
production is unaffected in gp91phox-deficient macrophages42 Cell Host & Microbe 7, 38–49, January 21, 2010 ª2010 Elsevier Ineven though chemical inhibitors of ROS suppress cytokine
secretion (Figures S3D and S3E). Together, these data indicate
that while some oxidative process may play a role, NADPH
phagocyte oxidase activation is not a viable mechanism by
which phagocytosis is coupled to inflammasome activation.
Similar to ROS production, intracellular rupture of phagolyso-
somes has been postulated to be a unifying mechanism by which
diverse particles activate inflammasomes (Halle et al., 2008;
Hornung et al., 2008). We observed that S. aureus PGN particles
remain quantitatively within intact acidified compartments after
internalization, suggesting that this mechanism cannot account
for PGN-induced IL-1b secretion (Figure S3B).
Since neither NADPH phagocyte oxidase nor lysosomal
rupture seemed to account for PGN-induced IL-1b secretion,
we explored whether other aspects of phagosome activity
were required. We treated macrophages with bafilomycin A1,
a specific inhibitor of the vacuolar proton pump (Herskovits
et al., 2007). Bafilomycin A1 treatment significantly suppressedc.
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tion (Figures 4A and 4B), indicating that phagosome acidification
is required for PGN-induced IL-1b secretion. The most abundant
enzyme responsible for PGN digestion in phagolysosomes is
lysozyme, and we therefore hypothesized that PGN degradation
by lysozyme might be the key to PGN-induced inflammasome
activation. We found that N,N0,N00-Triacetylchitotriose (triNAG),
an inhibitor of lysozyme (Dahlquist et al., 1966; Fukamizo et al.,
1992; Laible and Germaine, 1985; Lehrer and Fasman, 1967),
strongly inhibited IL-1b release from macrophages stimulated
with PGN (Figure 4C), while induction of TNF-a secretion was
not affected (Figure 4D). Moreover, triNAG did not have any effect
on IL-1b release from macrophages stimulated with either ATP or
alum after Pam3CSK4 priming (Figures 4E and 4F), indicating that
triNAG does not nonspecifically block IL-1b release or caspase-1
activation. Further, we observed that triNAG inhibits IL-1b
production induced by PGNs from other bacteria, including
Bacillus subtilis and Pseudomonas aeruginosa (Figure 4G).
Collectively, these results demonstrate that lysozyme activity
toward PGN particles is essential for inflammasome activation.
These data are intriguing, since the cell wall of pathogenic
S. aureus is known to be highly resistant to lysozyme (Bera
et al., 2005). However, most methods for preparing purified
PGN from S. aureus generate a product that is sensitive to lyso-
zyme (Gelius et al., 2003; Mellroth et al., 2003; Park et al., 2007).
Recently, Bera et al. reported that O-acetylation of MurNAc of
S. aureus PGN, a process catalyzed by O-acetyltransferase A
(OatA), is the specific modification that makes this PGN and
the bacterial cell wall lysozyme resistant (Bera et al., 2005).
PGN from S. aureus mutants lacking OatA (DoatA) is more sensi-
tive to lysozyme. We therefore hypothesized that if lysozyme-
based degradation is required for PGN-induced IL-1b secretion,
wild-type S. aureus should trigger significantly less IL-1b release
from macrophages than mutants with a lysozyme-sensitive
PGN. We infected macrophages with live wild-type and DoatA
mutant bacteria and monitored both intracellular survival and
IL-1b secretion. Macrophages more efficiently kill the DoatA
mutant (Figure 5A); however, despite the decreased bacterial
load in DoatA-treated cells, more IL-1b (Figure 5B) and more
IL-18 (Figure 5C) were secreted. Enhanced IL-1b and IL-18
release occurred under conditions where no significant changes
in TNF-a were observed (Figure 5C). DoatA bacteria stimulated
activation of caspase-1, as indicated by the appearance of the
cleaved p10 subunit, whereas wild-type bacteria did not
(Figure 5D).
The enhanced IL-1b produced in response to DoatA infection
is largely dependent on the NLRP3 inflammasome (Figure 5E).
Consistent with these data, PGN freshly purified from wild-type
S. aureus induces less IL-1b secretion than PGN purified from
DoatA bacteria, while they induced similar amounts of TNF-a
(Figure S4A). Further, as previously reported, the DoatA PGN
was significantly more sensitive to lysozyme in vitro than wild-
type PGN (data not shown). Enhanced inflammasome activation
has been associated with caspase-1-dependent cell death, or
pyroptosis (Bergsbaken et al., 2009). We therefore examined
whether DoatA bacteria induce significant macrophage cell
death. Infection of macrophages with wild-type or DoatA bac-
teria did not induce any cell death for up to 24 hr after infection
(Figure S4B).CellOur in vitro results demonstrated that the lysozyme resistance
of wild-typeS. aureus contributes not only to intracellular survival
but also to evasion of IL-1b secretion from macrophages. To
assess the significance of these observations to disease patho-
genesis, we used a murine subcutaneous challenge model. In
these studies, individual animals were injected simultaneously
in one flank with the wild-type S. aureus strain and in the oppo-
site flank with the DoatA mutant. At the site of DoatA injection,
mice developed sizeable abscess lesions reaching an average
size of 11 mm2 by day 1, but injection of an equivalent inoculum
of the wild-type bacteria on the contralateral flank failed to
produce visible lesions in most mice (Figures 6A and 6B).
Analysis of bacterial load in lesions after 2 days revealed
that wild-type bacteria survived better (Figure 6C), suggesting
that reduced inflammation correlates with enhanced bacterial
survival. Histological analysis confirmed that both strains of
bacteria induce formation of multiple abscesses under the
skin, but there were no clear differences in the morphology of
the abscesses (Figure S5A). To determine whether the increased
inflammatory response elicited by theDoatAmutant is due solely
to enhanced inflammasome activation, we treated mice with
anti-IL-1b/IL-18 antibodies and repeated the infection. In this
case, the wild-type and DoatA bacteria induced identical
amounts of inflammation (Figure 6D), while control antibody
treatment did not affect the difference between wild-type and
DoatA bacteria (Figure S5B). Thus, the data collectively demon-
strate that S. aureus evades inflammasome activation and
subsequent mucosal inflammation through chemical modifica-
tion of its cell wall PGN.
DISCUSSION
In this study, we have shown that bacterial cell wall degradation
in macrophage phagosomes is functionally linked to activation of
the inflammasome and IL-1b secretion. We demonstrated that
the particulate nature of cell wall PGN is essential for activation
of NLRP3 inflammasomes. Muramidase digestion of PGN
solubilized the particles and destroyed their ability to activate
inflammasomes, even though this treatment preserved the MDP
motif and the capacity to stimulate production of pro-IL-1b and
other cytokines. Further, phagocytosis and lysozyme-mediated
degradation of PGN are required to induce IL-1b secretion.
Modification of PGN by S. aureus to become resistant to lyso-
zyme not only protects the organism from lysozyme-based
killing in macrophages, it also strongly inhibits production of
IL-1b in response to infection in vitro and in vivo. This illustrates
a case whereby a bacterium specifically subverts IL-1b secretion
through chemical modification of its cell wall PGN.
The most common clinical manifestation of S. aureus is cuta-
neous infection, a highly localized infection in which IL-1b is
particularly important for orchestrating host defense. Miller
et al. demonstrated that neutrophil recruitment to sites of cuta-
neous infection is impaired in mice deficient in IL-1R, IL-1b, or
ASC and that the bacteria grow significantly faster at these sites
(Miller et al., 2006, 2007). Our data demonstrate that phagoso-
mal degradation of S. aureus cell wall PGN is a specific trigger
for NLRP3 inflammasome activation and that direct inhibition
of lysozyme in macrophages with triNAG strongly inhibits IL-1b
secretion. A variety of additional bacteria, including certainHost & Microbe 7, 38–49, January 21, 2010 ª2010 Elsevier Inc. 43
Figure 4. Phagosome Maturation and Lysozyme-Dependent Degradation Are Required for PGN to Induce IL-1b Secretion
(A and B) The vacuolar proton ATPase inhibitor bafilomycin A1 blocks S. aureus PGN-induced IL-1b secretion. BMDMs were preincubated with 0.1% DMSO or
the indicated doses of bafilomycin A1 for 30 min and then stimulated with PGN for 18 hr. Secretion of IL-1b and TNF-a was measured by ELISA.
(C and D) The lysozyme inhibitor triNAG blocks S. aureus PGN-induced IL-1b secretion. BMDMs were preincubated with equal volume of PBS or the
indicated doses of lysozyme inhibitor triNAG for 30 min and then stimulated with PGN for 18 hr. Secretion of IL-1b (C) and TNF-a (D) were measured by
ELISA.
(E) TriNAG does not directly inhibit the inflammasome. The same procedure was performed as in (C) and (D) except that cells were primed with Pam3CSK4
(1 mg/ml) for 16 hr and then pulsed with 5 mM ATP for the final 2 hr of the culture.
(F) BMDMs were primed with Pam3CSK4 (1 mg/ml). After 16 hr, culture media was replaced with fresh media, incubated with equal volume of PBS or triNAG for
30 min, and then stimulated with PGN (20 mg/ml) or alum (250 mg/ml) for 6 hr.
(G) TriNAG inhibits IL-1b secretion induced by PGN from other bacteria. BMDMs were stimulated as in (C) with PGNs (20 mg/ml) from the indicated bacteria.
Secretion of IL-1b was measured by ELISA. Results shown are representative of at least three independent experiments. Triplicate analysis was performed
for ELISA. Data are presented as mean + SD.
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Figure 5. S. aureus Reduces Macrophage IL-1b Secretion and Local Inflammatory Responses by Making Its PGN Resistant to Lysozyme
(A) BMDMs were infected with wild-type S. aureus (SA113 WT) or an OatA deletion mutant (DoatA) at the indicated multiplicities of infection (moi), and bacterial
survival was assessed at the indicated intervals. DoatA bacteria were killed more efficiently by macrophages than wild-type bacteria. Data are presented as
mean ± SD. Significant differences were determined using Student’s t test. **p < 0.01.
(B) BMDMs were infected at the indicated moi with wild-type or mutant S. aureus. After 20 hr, secretion of IL-1b into culture supernatant was measured by ELISA.
Despite the reduced bacterial numbers, DoatA bacteria stimulated more IL-1b secretion than wild-type bacteria. Results shown are representative of at least
three independent experiments. Triplicate analysis was performed for ELISA. Data are presented as mean + SD.
(C) BMDMs were infected at an moi of 25 and incubated for 18 hr. Cell supernatants were collected, and IL-18 and TNF-a were measured by ELISA. As a control,
cells were primed overnight with 100 ng/ml Pam3CSK4 and then stimulated for 2 hr with 5 mM ATP as indicated.
(D) BMDMs were infected at an moi of 25 and incubated for 18 hr. Cell supernatants were collected and immunoblotted for release of the mature p10 form of
caspase-1. As a control, cells were primed overnight with 100 ng/ml Pam3CSK4 and then stimulated for 2 hr with 5 mM ATP.
(E) BMDMs from wild-type mice or from mice deficient in the indicated genes were infected at the indicated moi with DoatA S. aureus. After 20 hr, secretion of
IL-1b into culture supernatant was measured by ELISA. The enhanced IL-1b produced by DoatA bacteria is largely dependent on the NLRP3 inflammasome. See
also Figure S4.
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Figure 6. DoatA S. aureus Induce More IL-1b/IL-18-Dependent Inflammation In Vivo Than Wild-Type Bacteria
(A) Mice (n = 24) were injected subcutaneously in opposite flanks with the two bacterial strains, and inflammatory lesion size was measured at the indicated times.
DoatA bacteria stimulated a significantly more robust local inflammatory response during the first 3 days after infection than wild-type bacteria.
(B) A representative pair of lesions after 2 days is depicted.
(C) Lesions after 2 days (n = 12) were harvested and plated to determine bacterial load. The larger DoatA-induced lesions contained significantly fewer bacteria
than the smaller lesions induced by wild-type bacteria.
(D) Mice (n = 12) were injected with anti-IL-1b and anti-IL-18 5 hr prior to infection subcutaneously in opposite flanks with the two bacterial strains, and inflam-
matory lesion size was measured at the indicated times. No significant differences were observed under these conditions. All data are presented as mean ± SEM.
Significant differences were determined using a paired Student’s t test. ***p < 0.0005; **p < 0.005; *p < 0.05. See also Figure S5.
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reported to possess different mechanisms for suppressing
lysozyme activity, and it is possible that such mechanisms may
also influence host IL-1b production and local inflammation.
It is widely appreciated that during serious infections, both
the pathogen and the host inflammatory response contribute
significantly to pathology. While treatments such as antibiotics
can rapidly control bacterial burden, clinical options for damp-
ening inflammatory immune responses are limited. Our findings
suggest that therapeutic approaches to control unwanted
inflammation might be developed by targeting lysozyme-based
PGN degradation in host immune cells.
A growing number of NLRP3 inflammasome activators have
been reported (Kanneganti et al., 2007b; Pe´trilli et al., 2007; Sut-
terwala et al., 2006; Ye and Ting, 2008), and these are generally
particulate or crystalline in nature. These include monosodium
urate crystals (Martinon et al., 2006), calcium pyrophosphate
dihydrate crystals (Martinon et al., 2006), silica (Cassel et al.,
2008; Dostert et al., 2008; Hornung et al., 2008), asbestos (Cas-
sel et al., 2008; Dostert et al., 2008), alum (Eisenbarth et al., 2008;
Franchi and Nu´n˜ez, 2008; Hornung et al., 2008; Kool et al., 2008;
Li et al., 2008), and hemozoin (Dostert et al., 2009; Shio et al.,
2009). The mechanisms by which phagocytosis of these diverse46 Cell Host & Microbe 7, 38–49, January 21, 2010 ª2010 Elsevier Inparticles is coupled to inflammasome activation are not yet clear.
Using antioxidants and gene knockdown, some studies have
demonstrated that ROS production is important for silica and
asbestos particles to activate NLRP3 inflammasomes, raising
the intriguing possibility that phagosome-associated respiratory
burst activity might be the link (Cassel et al., 2008; Dostert et al.,
2008). However, it is not clear whether all of these model parti-
cles induce phagocyte oxidase activity or whether all particles
that strongly activate the phagocyte NADPH oxidase would be
expected to activate the NLRP3 inflammasome. Subsequent
studies, in agreement with our results for PGN and alum, indicate
that inflammasome activation in response to silica, uric acid, and
hemozoin does not seem to involve the phagocyte NADPH
phagocyte oxidase that is responsible for phagosome-associ-
ated ROS production (Dostert et al., 2009). Further, the model
particle zymosan, which potently activates the phagocyte
NADPH oxidase, does not activate the inflammasome in BMDMs.
Taken together, the data may support a role for oxidases that are
not associated with phagocytosis in regulation of the inflamma-
some, but ROS production cannot explain the association of
phagocytosis with inflammasome activation.
Two recent reports have suggested that particulate inflamma-
some stimuli act through destabilization of phagosomalc.
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cytosol (Halle et al., 2008; Hornung et al., 2008). Hornung et al.
proposed that silica, monosodium urate crystals, and alum parti-
cles are internalized into macrophage phagosomes and cause
swelling and rupture of internal compartments, leading to IL-1b
secretion (Hornung et al., 2008). This model is attractive in that
it provides a general mechanism by which diverse particles
can activate the same inflammatory response from macro-
phages. In a related report, Halle et al. demonstrated that fibrillar
b-amyloid is phagocytosed by microglia and activates NLRP3
inflammasomes by phagosomal destabilization (Halle et al.,
2008). It has been reported that fibrillar b-amyloid is digested
relatively poorly by microglia (Frackowiak et al., 1992), and Halle
et al. suggest that resistance to degradation may contribute to
the loss of lysosomal integrity and subsequent inflammasome
activation (Halle et al., 2008). Although phagosomal destabiliza-
tion may be possible for PGN, it seems unlikely that loss of
phagosomal integrity is a normal part of phagocytic attack and
sensing of live microorganisms. Indeed, we observe that PGN
particles remain fully sequestered in acidic intracellular compart-
ments following phagocytosis. The simplest explanation is
that PGN products are released upon degradation and sensed
either within the phagosome or after transport into the cytosol.
Indeed, both NLRP3 and NLRP1 have been reported to directly
sense MDP (Faustin et al., 2007; Martinon et al., 2004), and it
is possible that release of MDP specifically in phagosomes
permits its delivery into the cytosol in a way that cannot be
mimicked by simply adding extracellular soluble MDP to cells.
Alternately, it is possible that phagosomes have a generic
mechanism of sensing degradation of polymers. Further studies
will be necessary to establish this part of the underlying
mechanism.
EXPERIMENTAL PROCEDURES
Mice and Cells
Caspase-1-deficient (Kuida et al., 1995) (kindly provided by Richard Flavell,
Yale University; New Haven, CT), NLRP3-deficient (Mariathasan et al., 2006),
Ipaf-deficient (Mariathasan et al., 2004), and ASC-deficient mice (Mariathasan
et al., 2004) (kindly provided by Vishva Dixit, Genentech; South San Francisco,
CA) were maintained in specific pathogen-free conditions at the Institute
for Systems Biology (Seattle, WA). C57BL/6, CD-1, Nod2-deficient, and
gp91phox-deficient mice were obtained from the Jackson Laboratory and
were maintained in specific pathogen-free conditions at Cedars-Sinai Medical
Center. All mice were cared for under institutional IACUC approval. BMDMs
from wild-type or mutant mice backcrossed onto the C57BL/6 background
were cultured in RPMI 1640 media containing 10% L929 cell supernatant,
10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine
for 6 days before use. Wild-type SA113 and isogenic DoatA S. aureus were
as previously described (Bera et al., 2005).
Reagents
Pam3CSK4, MDP, and purified LTA fromStaphylococcus aureuswere obtained
from InvivoGen (San Diego, CA). PGNs from Staphylococcus aureus and
Bacillus subtilis were from Sigma-Aldrich (St. Louis). Cytochalasin D, ATP,
zymosan, and triNAG were from Sigma-Aldrich. Alum (Imject Alum) was from
Thermo Scientific (Waltham, MA).
Macrophage Intracellular Survival Assays
Intracellular survival assays were performed according to a previous report (Liu
et al., 2005). Wild-type SA113 and DoatA bacteria were grown for 18–24 hr to
reach stationary phase. Concentration was checked by spectrophotometer
and confirmed by counting cfu on LB-agar plates. Bacterial cultures wereCellwashed in PBS. Serial dilutions of bacteria were made for several multiplicities
of infection (moi) in RPMI 1640 + 10% FCS. Diluted bacteria cultures were
added onto 1 3 105 BMDMs/100 ml/well in the same media (moi = from
50 to 3), centrifuged at 5153 g for 4 min, then incubated at 37C in a 5%
CO2 incubator for 30 min. Wells were washed three times with PBS, and
Gentamicin (final concentration 300 mg/ml GIBCO BFL) was added in the fresh
media to kill extracellular bacteria. After 1 hr, culture media was replaced with
fresh media containing 100 mg/ml Gentamicin to avoid killing of intracellular
bacteria by high concentration of the antibiotic. At specified time points,
BMDMs were washed three times with PBS and lysed in 0.02% Triton
X-100, and cfu were calculated by plating on LB-agar. Culture supernatants
were collected after 20 hr for ELISA.
Murine Model of Subcutaneous Infection
Male CD-1 mice (10–16 weeks old) were injected subcutaneously in one flank
(chosen randomly) with (53 107 cfu) wild-type S. aureus and simultaneously in
the opposite flank with the same dose of DoatA mutant strain for direct
comparison. Bacterial cultures were washed, diluted, and resuspended in
PBS, following an established protocol for generating localized S. aureus
subcutaneous infection (Nizet et al., 2001). Lesion size, as assessed by the
maximal length 3 width of the developing ulcers, was recorded daily. Where
indicated, mice were injected i.p. with 12.5 mg each of anti-IL-1b and anti-IL-
18 antibodies (R&D Systems; Minneapolis) 5 hr prior to infection. Control
mice were injected with 25 mg of rat IgG.
Immunoblot
For detection of pro-IL-1b and processed IL-1b, BMDMs were resuspended
in Opti-MEM media seeded into 6-well plates and stimulated for 18 hr as
indicated in figure legends. After clarification by centrifugation, protein in the
1.5 ml supernatants was precipitated with 20 ml Strataclean resin (Stratagene;
La Jolla, CA) and resuspended in sample buffer. Cells were lysed in SDS-PAGE
sample buffer with protease inhibitor cocktail (Sigma). Samples were boiled for
5 min, proteins were separated by SDS-PAGE and transferred to immobilon-P
membrane, and IL-1b protein was detected by immunoblot with monoclonal
antibody 3ZD (obtained from Biological Resources Branch of National Cancer
Institute at Frederick, MD).
Phagocytosis Assay
Macrophages were preincubated as indicated with cytochalasin D (5 mM) or
vehicle control (0.1% DMSO) for 30 min and were subsequently incubated
with FITC-labeled PGN (10 mg/ml) for 4 hr. Cells were washed and lifted in
PBS containing 1 mM EDTA, 1 mM sodium azide, and 2.4 U/ml Proteinase K
(to remove bound but uninternalized PGN particles) prior to analysis by flow
cytometry.
Measurement of Cytokines
IL-1b (eBioscience; San Diego, CA), IL-18 (Medical & Biological Laboratories;
Nagoya, Japan), and TNF-a (BD Biosciences; San Jose, CA) levels in culture
supernatants were assayed using ELISA kits according to the manufacturers’
instructions.
Statistics
In vitro data are typically presented as mean ± standard deviation of a single
experiment and are representative of three or more independent experiments.
For in vivo experiments, lesion sizes were compared using the paired Student’s
t test.
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